TrademarkDir
HOPA HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION
LIVE

Serial Number

87445533

Owner

Hematology Oncology Pharmacy Association, Inc.

Attorney

Melissa A. Vallone

Filing Date

May 11, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HOPA HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION Trademark

Serial Number: 87445533 • Registration: 5809843

HOPA HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION is a trademark filed by Hematology Oncology Pharmacy Association, Inc. on May 11, 2017. The trademark is classified under Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Hematology Oncology Pharmacy Association, Inc. (3 trademarks)

555 E. Wells St.
Milwaukee, WI 53202

Entity Type: 99

Trademark Details

Filing Date

May 11, 2017

Registration Date

July 23, 2019

Published for Opposition

May 7, 2019

Goods & Services

Educational services, namely, providing educational conferences and webinars, in the field of hematology/oncology pharmacy

Association services, namely, promoting and supporting pharmacy practitioners in the area of hematology/oncology to achieve advances in the optimization of care of individuals affected by cancer

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 6, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 6, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 5, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Feb 12, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 23, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2018 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2018 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 2, 2018 GNRN
NON-FINAL ACTION E-MAILED
Feb 2, 2018 GNRT
NON-FINAL ACTION WRITTEN
Feb 2, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 1, 2018 TROA
ASSIGNED TO EXAMINER
Jan 9, 2018 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 11, 2017 GNRN
NON-FINAL ACTION E-MAILED
Aug 11, 2017 GNRT
NON-FINAL ACTION WRITTEN
Aug 11, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 10, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 17, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2017 NWOS
NEW APPLICATION ENTERED
May 15, 2017 NWAP

Related Trademarks

More from this Owner

HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC)

HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC)

HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC)

HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC)

HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC)

HOPA ORAL CHEMOTHERAPY COLLABORATIVE (OCC)

PHARMACISTS OPTIMIZING CANCER CARE

PHARMACISTS OPTIMIZING CANCER CARE

PHARMACISTS OPTIMIZING CANCER CARE

PHARMACISTS OPTIMIZING CANCER CARE

PHARMACISTS OPTIMIZING CANCER CARE

PHARMACISTS OPTIMIZING CANCER CARE